OrphanDrug
OrphanDrug
Pharma Knowledge Base

acitretin/etretinate embryopathy

MeSH: C538169ORPHA: 40366

Contents

  1. 1. Available Treatments
  2. 2. Clinical Presentation
  3. 3. Classification & Codes

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with acitretin/etretinate embryopathy, sourced from HPO and Orphanet clinical annotations.

High palateMicrocephalyEpicanthusMicrognathiaCupped earAnteverted naresAbnormal retinal morphologyHypoplasia of the thymusPremature birthBradycardiaConotruncal defectAbnormal facial shapeHypoplastic nasal septumAtrioventricular canal defectAplasia/Hypoplasia of the optic nerveAbnormality of the calcaneusMicrotiaBilateral sensorineural hearing impairmentMedian cleft palateAplasia/Hypoplasia of the maxillaNeurodevelopmental abnormalityPreauricular skin tagThird degree atrioventricular blockAplasia/hypoplasia involving bones of the lower limbsAplasia/hypoplasia involving bones of the upper limbsAntecubital pterygium

Classification & Codes

MeSH Code

C538169

Orphanet Code

ORPHA:40366
acitretin/etretinate embryopathy
MeSHC538169
OrphanetORPHA:40366
Treatments0 drug(s)
Symptoms on record26 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO